
Low-cost generic drug programs have large gaps in coverage for core evidence-based CVD medications: Study
A cross-sectional study of 19 low-cost generic programs (LCGPs) found that their medication coverage for six cardiovascular diseases (CVD) varied significantly between programs. Of all analyzed programs, Mark Cuban Cost Plus ...
Sep 4, 2023
0
1